Right Price
-10%
portes grátis
Right Price
A Value-Based Prescription for Drug Costs
Neumann, Peter J.; Cohen, Joshua T.; Ollendorf, Daniel A.
Oxford University Press Inc
06/2021
274
Dura
Inglês
9780197512883
15 a 20 dias
498
Descrição não disponível.
Acknowledgments
Preface
PART 1: THE ECONOMICS OF PRESCRIPTION DRUGS
Chapter 1: Introduction
Chapter 2: The prescription drug market
Chapter 3: Proposed solutions for rising drug prices
Chapter 4: Measuring the value of prescription drugs
PART 2: EXPERIENCES MEASURING A DRUG'S VALUE IN THE US AND ABROAD
Chapter 5: Measuring drug value: Whose job is it anyway?
Chapter 6: Institute for Clinical and Economic Review (ICER)
Chapter 7: Other US value assessment frameworks
Chapter 8: Do drugs for special populations warrant higher prices?
PART 3: GETTING TO VALUE-BASED PRICING FOR DRUGS
Chapter 9: Improving value measurement
Chapter 10: Aligning prices with value
Chapter 11: The path forward
Index
Preface
PART 1: THE ECONOMICS OF PRESCRIPTION DRUGS
Chapter 1: Introduction
Chapter 2: The prescription drug market
Chapter 3: Proposed solutions for rising drug prices
Chapter 4: Measuring the value of prescription drugs
PART 2: EXPERIENCES MEASURING A DRUG'S VALUE IN THE US AND ABROAD
Chapter 5: Measuring drug value: Whose job is it anyway?
Chapter 6: Institute for Clinical and Economic Review (ICER)
Chapter 7: Other US value assessment frameworks
Chapter 8: Do drugs for special populations warrant higher prices?
PART 3: GETTING TO VALUE-BASED PRICING FOR DRUGS
Chapter 9: Improving value measurement
Chapter 10: Aligning prices with value
Chapter 11: The path forward
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Acknowledgments
Preface
PART 1: THE ECONOMICS OF PRESCRIPTION DRUGS
Chapter 1: Introduction
Chapter 2: The prescription drug market
Chapter 3: Proposed solutions for rising drug prices
Chapter 4: Measuring the value of prescription drugs
PART 2: EXPERIENCES MEASURING A DRUG'S VALUE IN THE US AND ABROAD
Chapter 5: Measuring drug value: Whose job is it anyway?
Chapter 6: Institute for Clinical and Economic Review (ICER)
Chapter 7: Other US value assessment frameworks
Chapter 8: Do drugs for special populations warrant higher prices?
PART 3: GETTING TO VALUE-BASED PRICING FOR DRUGS
Chapter 9: Improving value measurement
Chapter 10: Aligning prices with value
Chapter 11: The path forward
Index
Preface
PART 1: THE ECONOMICS OF PRESCRIPTION DRUGS
Chapter 1: Introduction
Chapter 2: The prescription drug market
Chapter 3: Proposed solutions for rising drug prices
Chapter 4: Measuring the value of prescription drugs
PART 2: EXPERIENCES MEASURING A DRUG'S VALUE IN THE US AND ABROAD
Chapter 5: Measuring drug value: Whose job is it anyway?
Chapter 6: Institute for Clinical and Economic Review (ICER)
Chapter 7: Other US value assessment frameworks
Chapter 8: Do drugs for special populations warrant higher prices?
PART 3: GETTING TO VALUE-BASED PRICING FOR DRUGS
Chapter 9: Improving value measurement
Chapter 10: Aligning prices with value
Chapter 11: The path forward
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
